U.S. Markets close in 1 hr 33 mins
  • S&P 500

    4,394.90
    -24.25 (-0.55%)
     
  • Dow 30

    34,908.33
    -176.20 (-0.50%)
     
  • Nasdaq

    14,675.44
    -102.83 (-0.70%)
     
  • Russell 2000

    2,225.44
    -14.59 (-0.65%)
     
  • Crude Oil

    74.09
    +0.47 (+0.64%)
     
  • Gold

    1,816.90
    -18.90 (-1.03%)
     
  • Silver

    25.52
    -0.26 (-1.00%)
     
  • EUR/USD

    1.1861
    -0.0035 (-0.2965%)
     
  • 10-Yr Bond

    1.2310
    -0.0380 (-2.99%)
     
  • Vix

    18.08
    +0.38 (+2.15%)
     
  • GBP/USD

    1.3894
    -0.0064 (-0.4585%)
     
  • USD/JPY

    109.7970
    +0.3360 (+0.3070%)
     
  • BTC-USD

    39,148.58
    -445.02 (-1.12%)
     
  • CMC Crypto 200

    929.87
    -20.03 (-2.11%)
     
  • FTSE 100

    7,032.30
    -46.12 (-0.65%)
     
  • Nikkei 225

    27,283.59
    -498.83 (-1.80%)
     

Taro to Announce First Quarter Results on July 27, 2021

·1 min read

HAWTHORNE, N.Y., July 21, 2021--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2021, after the close of market on Tuesday, July 27, 2021.

The release will be accessible on Taro’s website at www.taro.com.

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210720006288/en/

Contacts

Daphne Huang
VP, CFO
(914) 345-9001
Daphne.Huang@Taro.com

William J. Coote
AVP, Treasurer and Investor Relations
(914) 345-9001
William.Coote@Taro.com